Beverly Hills, CANCT06244992Now EnrollingIRB Ready

Solid Tumors Clinical Trial in Beverly Hills, CA

Access cutting-edge solid tumors treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.

Sponsored by Pyrotech Therapeutics, Inc.

Quick Self-Assessment

See if you qualify for this Beverly Hills location

Preparing your pre-screening questions...

Expert Care in Beverly Hills

Access solid tumors specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related solid tumors treatment provided free

Apply for This Beverly Hills Location

Check if you qualify for this solid tumors clinical trial in Beverly Hills, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Beverly Hills

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Beverly Hills site if eligible
  4. 4Begin participation

About This Solid Tumors Study in Beverly Hills

This Phase 1/2a study will explore the safety and efficacy of PTT-936, an Alpha Kinase 1 (ALPK1) activator, used alone or in combination with anti-PD-1/L1 therapy in patients with locally advanced or metastatic solid tumors. The study is divided into two parts: Phase 1 (Part A) focuses on determining the pharmaceutically active dosage range and evaluating the safety profile of PTT-936 when administered as a monotherapy. Phase 2a (Part B) will assess the safety and efficacy of PTT-936 combined wi

Sponsor: Pyrotech Therapeutics, Inc.

Who Can Participate

Inclusion Criteria

Voluntarily signed informed consent form (ICF). 2. Ability and willingness to adhere to all study procedures. 3. Male or female patients ≥ 18 years of age at the time of signing the ICF. 4. Locally advanced unresectable or metastatic solid tumor confirmed by histology or cytology 5. For Part A: On tumor imaging, as assessed by RECIST v1.1 and iRECIST, with measurable or unmeasurable disease. For Part B: On tumor imaging, as assessed by RECIST v1.1 and iRECIST, with at least one measurable disease. 6. Life expectancy ≥ 3 months. 7. Eastern Cooperative Oncology Group (ECOG) performance status (PS): 0-1 for Part A and Part B. 8. Adequate end-organ and hematopoietic function, defined based on the following laboratory results obtained within 7 days prior to the first dose of study treatment \[Day 1\]): 1. Absolute neutrophil count (ANC) ≥ 1.5×109/L (1500/μL), without granulocyte colony-stimulating factor (G-CSF) support. Note that G-CSF may be administered until

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Beverly Hills?

Yes, this clinical trial (NCT06244992) has an active research site in Beverly Hills, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Solid Tumors Treatment Options in Beverly Hills, CA

If you're searching for solid tumors treatment options in Beverly Hills, CA, this clinical trial (NCT06244992) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all solid tumors clinical trials near you to find additional studies recruiting in your area.

More Advanced Solid Tumors Trials in Beverly Hills, CA

See all advanced solid tumors clinical trials recruiting in Beverly Hills — not just this study.

Browse Advanced Solid Tumors Trials in Beverly Hills →

Browse More Trials by Condition

Advanced Solid Tumors TrialsAll Conditions →

Ready to Join in Beverly Hills?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Beverly Hills, CA